silicon phthalocyanine pc4 has been researched along with Cancer of Liver in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kim, J; Lee, S; Na, K | 1 |
Chen, JJ; Huang, YZ; Song, MR; Xue, JP; Zhang, ZH | 1 |
Huang, JD; Shen, XM; Zhang, HH; Zheng, BY | 1 |
Cai, Y; Huang, JD; Lin, AL; Shen, XM; Yang, XM; Zhang, HH; Zheng, BY | 1 |
4 other study(ies) available for silicon phthalocyanine pc4 and Cancer of Liver
Article | Year |
---|---|
Glycyrrhetinic Acid-Modified Silicon Phthalocyanine for Liver Cancer-Targeted Photodynamic Therapy.
Topics: Animals; Glycyrrhetinic Acid; Indoles; Liver Neoplasms; Mice; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents | 2021 |
Silicon Phthalocyanines Axially Disubstituted with Erlotinib toward Small-Molecular-Target-Based Photodynamic Therapy.
Topics: Antineoplastic Agents; Cell Survival; ErbB Receptors; Erlotinib Hydrochloride; Hep G2 Cells; Humans; Indoles; Light; Liver Neoplasms; Microscopy, Confocal; Organosilicon Compounds; Photochemotherapy; Photosensitizing Agents; Polyethylene Glycols; Reactive Oxygen Species; Zinc | 2017 |
[Synthesis and photodynamic anticancer activity of silicon phthalocyanine axially modified by nucleoside derivatives].
Topics: Antineoplastic Agents; Hep G2 Cells; Humans; Indoles; Liver Neoplasms; Microscopy, Confocal; Microscopy, Fluorescence; Nucleosides; Organosilicon Compounds; Photosensitizing Agents | 2013 |
[Non-covalent albumin conjugates of silicon (IV) phthalocyanines axially substituted with nucleoside: preparation and in vitro photodynamic activities].
Topics: Animals; Cattle; Hep G2 Cells; Humans; Indoles; Liver Neoplasms; Nucleosides; Organosilicon Compounds; Serum Albumin, Bovine; Spectrometry, Fluorescence | 2015 |